Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL

NCT00738829 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Interventions

DRUG: Lenalidomide
DRUG: Fludarabine
BIOLOGICAL: Rituximab

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]
[object Object]